| Crocus sativus L. Versus Methylphenidate in Treatment of Children with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Pilot Study S Baziar, A Aqamolaei, E Khadem, SH Mortazavi, S Naderi, ... Journal of child and adolescent psychopharmacology 29 (3), 205-212, 2019 | 65 | 2019 |
| L-Carnosine combination therapy for major depressive disorder: A randomized, double-blind, placebo-controlled trial B Araminia, M Shalbafan, A Mortezaei, E Shirazi, S Ghaffari, ... Journal of Affective Disorders 267, 131-136, 2020 | 36 | 2020 |
| Comparison of vortioxetine and sertraline for treatment of major depressive disorder in elderly patients: A double‐blind randomized trial F Borhannejad, B Shariati, S Naderi, M Shalbafan, A Mortezaei, ... Journal of Clinical Pharmacy and Therapeutics 45 (4), 804-811, 2020 | 27 | 2020 |
| 5-Hydroxytryptophan as adjuvant therapy in treatment of moderate to severe obsessive-compulsive disorder: a double-blind randomized trial with placebo control F Yousefzadeh, E Sahebolzamani, A Sadri, A Mortezaei, A Aqamolaei, ... International Clinical Psychopharmacology 35 (5), 254-262, 2020 | 23 | 2020 |
| Amantadine as adjuvant therapy in the treatment of moderate to severe obsessive–compulsive disorder: a double‐blind randomized trial with placebo control S Naderi, H Faghih, A Aqamolaei, SH Mortazavi, A Mortezaei, ... Psychiatry and Clinical Neurosciences 73 (4), 169-174, 2019 | 20 | 2019 |
| Cinnamomum tamala as an adjuvant therapy in the treatment of major depressive disorder: A double-blind, randomized, placebo-controlled clinical trial with placebo control S Ghaffari, A Ghobadi, AH Jamshidi, SH Mortazavi, S Naderi, ... Advances in Integrative Medicine 7 (3), 141-147, 2020 | 10 | 2020 |
| Medication adherence and its possible associated factors in patients with acne vulgaris: A cross‐sectional study of 200 patients in Iran J Salamzadeh, S Torabi Kachousangi, S Hamzelou, S Naderi, ... Dermatologic Therapy 33 (6), e14408, 2020 | 8 | 2020 |
| Inadequate achievement of ABC goals (HbA1c, blood pressure, LDL-C) among patients with type 2 diabetes in an Iranian population, 2012–2017 M Larry, S Alizadeh, S Naderi, B Salekani, MA Mansournia, S Rabizadeh, ... Diabetes & Metabolic Syndrome: Clinical Research & Reviews 14 (4), 619-625, 2020 | 8 | 2020 |
| Levetiracetam adjunct to quetiapine for the acute manic phase of bipolar disorder: a randomized, double-blind and placebo-controlled clinical trial of efficacy, safety and … F Zarezadeh, M Arbabi, A Shamabadi, S Naderi, A Hasanzadeh, ... International Clinical Psychopharmacology 37 (2), 46-53, 2022 | 5 | 2022 |
| Evaluation of the effect of Transversus Abdominis Plane (TAP) block on post-laparoscopic cholecystectomy stress responses: a randomized controlled trial A Saliminia, RA Yekta, O Azimaraghi, A Shamabadi, S Naderi, ... Archives of Anesthesiology and Critical Care 8 (Supplement), 399-406, 2022 | 1 | 2022 |
| Advances in Integrative Medicine S Ghaffari, A Ghobadi, AH Jamshidi, SH Mortazavi, S Naderi, ... | | 2019 |
Shahin AkhondzadehPsychiatric Research Center, Roozbeh Hospital, Tehran University of Medical Sciences, Iran在 neda.net 的电子邮件经过验证
